Company

Management Team

Our Executive Team is comprised of a mix of innovative, experienced, and scientific-minded leaders who have set the tone for GenomOncology's ambitious and driven culture.

MANUEL J.
GLYNIAS

Our CEO, is a serial entrepreneur with over 25 years of experience in bioinformatics. Prior to GenomOncology, Manuel was a partner at Rosetta where he helped develop big data solutions for e-commerce clients, and was the founder and CEO of NetGenics, a venture-backed provider of discovery informatics. He also developed a number of commercial software platforms including MacGene, Gene Works, and Primer Express.

KELLY
CHOI, MD

Our Chief Commercial Officer, Dr. Kelly Choi has over 20 years of healthcare experience most recently as one of the founding members of Cota, Inc, a healthcare technology company focused on measuring real-world clinical outcomes in oncology. In addition, she held various executive roles at QuantiaMD (now part of Aptus Health). She has also been at Novartis Pharmaceuticals and McKinsey & Company.

TERESA
FLETCHER, CHP

Our Vice President of Business Development, is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales and prior to joining GenomOncology, she held positions at various healthcare startups within sales and customer management in the healthcare IT, healthcare informatics, and medical device industries.

IAN
MAURER

Our Chief Technology Officer, leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant and Rosetta. He has his Bachelors and Masters degrees in Computer Engineering from Syracuse University.

GINA
DROBNICK

Our Vice President of Client Services, has more than 25 years of experience in professional services as both a management consultant and an operations executive with a variety of public and private organizations. Prior to GO, Gina was employed by Ernst & Young, Arthur Andersen, Brulant as an Associate Partner in their Creative group, and Level Seven, Inc. as their Chief Operating Officer. She also launched her own consulting practice in 2001.

JUSTIN
YEAKLEY

Our Vice President of Product Development develops, supports, supervises all activities related to the design, development, and implementation of the GenomOncology's applications. Justin has over 12 years of software development and leadership experience. Prior to working at GenomOncology, Justin was a Director of Application Development at Rosetta where he was responsible for the design, delivery, and quality of numerous MM dollar projects.

JEFF
SMITH

Our Vice President of Finance has more than 24 years of experience in the areas of accounting, finance, operations, and business development. Prior to joining GenomOncology, Jeff was employed as Chief Financial Officer for several Private Equity backed lower middle-market companies both domestically and abroad, including in the United Kingdom, Chile, and Brazil. Jeff is a CPA and holds an active license in the state of Ohio.
  • MANUEL J.
    GLYNIAS


    Our CEO, is a serial entrepreneur with over 25 years of experience in bioinformatics. Prior to GenomOncology, Manuel was a partner at Rosetta where he helped develop big data solutions for e-commerce clients, and was the founder and CEO of NetGenics, a venture-backed provider of discovery informatics. He also developed a number of commercial software platforms including MacGene, Gene Works, and Primer Express.

  • KELLY
    CHOI, MD


    Our Chief Commercial Officer, Dr. Kelly Choi has over 20 years of healthcare experience most recently as one of the founding members of Cota, Inc, a healthcare technology company focused on measuring real-world clinical outcomes in oncology. In addition, she held various executive roles at QuantiaMD (now part of Aptus Health). She has also been at Novartis Pharmaceuticals and McKinsey & Company.

  • TERESA
    FLETCHER, CHP


    Our Vice President of Business Development, is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales and prior to joining GenomOncology, she held positions at various healthcare startups within sales and customer management in the healthcare IT, healthcare informatics, and medical device industries.

  • IAN
    MAURER


    Our Chief Technology Officer, leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant and Rosetta. He has his Bachelors and Masters degrees in Computer Engineering from Syracuse University.

  • GINA
    DROBNICK


    Our Vice President of Client Services, has more than 25 years of experience in professional services as both a management consultant and an operations executive with a variety of public and private organizations. Prior to GO, Gina was employed by Ernst & Young, Arthur Andersen, Brulant as an Associate Partner in their Creative group, and Level Seven, Inc. as their Chief Operating Officer. She also launched her own consulting practice in 2001.

  • JUSTIN
    YEAKLEY


    Our Vice President of Product Development develops, supports, supervises all activities related to the design, development, and implementation of the GenomOncology's applications. Justin has over 12 years of software development and leadership experience. Prior to working at GenomOncology, Justin was a Director of Application Development at Rosetta where he was responsible for the design, delivery, and quality of numerous MM dollar projects.

  • JEFF
    SMITH


    Our Vice President of Finance has more than 24 years of experience in the areas of accounting, finance, operations, and business development. Prior to joining GenomOncology, Jeff was employed as Chief Financial Officer for several Private Equity backed lower middle-market companies both domestically and abroad, including in the United Kingdom, Chile, and Brazil. Jeff is a CPA and holds an active license in the state of Ohio.

Schedule a demo